| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Division of Hematology and Oncology, Cedars-Sinai Medical Center [H. J. M., N. N. S-S., R. A. V., M. K., A. M., K. P., D. B., J. R. B.], Division of Hematology and Oncology, Veterans Affairs Greater Los Angeles Health Care System [M. P., C. H. W., J. Z., L. Z., G. C.], Division of Pathology [J. W. S.], University of California Los Angeles School of Medicine, and Jonsson Comprehensive Cancer Center [H. J. M., N. N. S-S., R. A. V., M. K., A. M., M. P., K. P., D. B., C. H. W., J. Z., L. Z., G. C., J. R. B.], Los Angeles, California 90048; Department of Hematology, Ibni Sina Hospital, Sihhiye Ankara, Turkey [M. B.]; and BIS Laboratories, Reseda, California [T. J. M.]
ABSTRACT
Human herpesvirus 8 (HHV-8), also known as Kaposis sarcoma-associated herpesvirus, has been implicated in the pathogenesis of Kaposis sarcoma (KS), primary effusion lymphoma (PEL), multicentric Castlemans disease, and recently multiple myeloma (MM). DNA sequence analyses of HHV-8 suggest that multiple HHV-8 strains exist. We extracted DNA from 24 patients with MM and 3 patients with monoclonal gammopathy of undetermined significance and compared HHV-8 open reading frames (ORFs) 26 and 65 sequences with those derived from patients with KS, PEL, and two HHV-8-positive PEL cell lines KS-1 and BC-1. ORF26 sequence data suggest that MM patients are consistently carriers of HHV-8 strain subtype C3. All MM patients also consistently revealed either a single bp deletion or substitution at position 112197 in ORF65. This unique alteration is not present in patients with KS or PEL or in PEL cell lines. It occurs in the portion of ORF65 that is known to be responsible for a serological response to HHV-8.
This article has been cited by other articles:
![]() |
A. M. Polstra, R. van den Burg, J. Goudsmit, and M. Cornelissen Human Herpesvirus 8 Load in Matched Serum and Plasma Samples of Patients with AIDS-Associated Kaposi's Sarcoma J. Clin. Microbiol., December 1, 2003; 41(12): 5488 - 5491. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Endo, T. Miura, T. Koibuchi, H. Nakamura, T. Takahashi, T. Odawara, M. Goto, A. Ajisawa, A. Iwamoto, and T. Nakamura Molecular Analysis of Human Herpesvirus 8 by Using Single Nucleotide Polymorphisms in Open Reading Frame 26 J. Clin. Microbiol., June 1, 2003; 41(6): 2492 - 2497. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Brander, N. Raje, P. G. O'Connor, F. Davies, J. Davis, D. Chauhan, T. Hideshima, J. Martin, D. Osmond, D. H. Kedes, et al. Absence of biologically important Kaposi sarcoma-associated herpesvirus gene products and virus-specific cellular immune responses in multiple myeloma Blood, June 28, 2002; 100(2): 698 - 700. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |